Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Minerva Neurosciences, Inc. (NERV) Form 8-K — Aug 12, 2026

$NERVForm 8-KItems 5.02Filed Aug 12, 2026, 4:05 PM ET0001193125-26-346817Original filing

Minerva Neurosciences appointed Anthony Aliquo, its Vice President and Controller, as Chief Accounting Officer and principal accounting officer effective August 10, 2026. The Board approved the appointment, disclosed under Item 5.02 of an 8-K filed August 12, 2026. CFO Fred Ahlholm ceased to serve as principal accounting officer on the same date but continues as Chief Financial Officer and principal financial officer, leaving the company's finance leadership otherwise intact. Aliquo, 39, is a CPA with more than 10 years of accounting experience, including audit roles at BDO USA and Deloitte & Touche, and has been with Minerva since September 2020.

Key figures

Appointee Age
39
Annual Base Salary
296696
Salary Effective Date
July 1, 2026
Bonus Target Percent Of Base
35

Price after filing

1 day: +10.2%7 days: +22.2%30 days: +5.9%

Close on the filing date to close N calendar days later (from $3.92). Historical, not a forecast.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    Minerva Neurosciences, Inc. (NERV) Form 8-K — Aug 12, 2026: AI Analysis | Signal8